pET21c(+)-EFG1mt
(Plasmid
#31076)
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 31076 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepET-21c(+)
-
Backbone manufacturerNovagen
- Backbone size w/o insert (bp) 5400
-
Vector typeBacterial Expression
-
Selectable markerschloramphenicol
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsBL21(DE3)(RIL). The RIL plasmid provides the isoacceptor tRNAs for Arg, Ile, Leu and the Chloramphenicol resistance
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameMature form human mitochondrial elongation factor G isoform 1
-
Alt nameGFM1
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2145
-
MutationIncludes the coding sequence for the mature form. Amino acids 36-751.
-
Entrez GeneGFM1 (a.k.a. COXPD1, EFG, EFG1, EFGM, EGF1, GFM, hEFG1, mtEF-G1)
-
Tag
/ Fusion Protein
- His (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NdeI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer T7
- 3′ sequencing primer T7-term (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pET21c(+)-EFG1mt was a gift from Linda Spremulli (Addgene plasmid # 31076 ; http://n2t.net/addgene:31076 ; RRID:Addgene_31076) -
For your References section:
Expression and characterization of isoform 1 of human mitochondrial elongation factor G. Bhargava K, Templeton P, Spremulli LL. Protein Expr Purif. 2004 Oct . 37(2):368-76. 10.1016/j.pep.2004.06.030 PubMed 15358359